Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis
NCT07175857
· ctgov
active_not_recruiting
- Enrollment
- 400
- Start
- 2025-07-21
- Completion
- 2026-09-30
- Last updated
- 2026-06-08
- Has results
- False
- Countries
- France
Conditions
Tagged with
Interventions
-
Lyv Endo app
DEVICE
Lyv Endo is a CE-marked Class I therapeutic digital medical device offering a patient-centered, integrative approach. Its innovation lies in its ability to deliver personalized content based on symptoms, surpassing the limits of traditional care.
Eligibility criteria
Inclusion Criteria:
* Women ≥18 years old
* with confirmed endometriosis diagnosis
* symptomatic patients (NRS ≥ 4 on one or more symptoms)
* French-speaking
* Owning a smartphone with internet/data,
* covered by French social security
Exclusion Criteria:
* Planned surgery during the study or surgery in the past 8 weeks
* Fertility hormone treatment during study
* Previous use of full Lyv Endo app or pilot program
* Pregnant or breastfeeding
* Under legal protection (guardianship, etc.)
* Cognitive or psychiatric conditions compromising consent
* Judged non-autonomous by investigator
* Participation in another interventional study
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine